Partner Headlines - LLY

  1. New Type 2 Diabetes Treatment Jardiance Tablets For Adults Now ...

    Benzinga
  2. UPDATE: Tigress Initiates Coverage On Eli Lilly

    Benzinga
  3. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga
  4. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical ...

    Benzinga
  5. Thursday Morning Earnings Reports

    Benzinga
  6. Earnings Scheduled For July 24, 2014

    Benzinga
  7. New Study Shows Beta-Amyloid Imaging Is Associated With Altered ...

    Benzinga
  8. Lilly And Immunocore Enter Immunotherapy Agreement To Co-Discover ...

    Benzinga
  9. Benzinga's Top #PreMarket Gainers

    Benzinga
  10. US Stock Futures Mostly Higher Ahead Of Goldman Sachs Earnings

    Benzinga
  11. Barclays Downgrades Pharmaceutical Sector

    Benzinga
  12. UPDATE: Barclays Upgrades Eli Lilly Despite Sector Downgrade

    Benzinga
  13. Benzinga's Top Upgrades

    Benzinga
  14. Eli Lilly is on the Right Track

    GuruFocus
  15. Celgene Sees Better Results For Psoriatic Arthritis

    IBD
  16. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness
  17. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  18. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  19. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica ...

    Benzinga
  20. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus
  21. Lilly Says Abemaciclib in Phase 1 Study Demonstrated Single-Agent ...

    Benzinga
  22. Eli Lilly insulin trial succeeds

    IBD
  23. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  24. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  25. Eli Lilly's Basal Insulin Outperforms Lantus In Trial

    IBD
  26. UPDATE: Eli Lilly Announces Peglispro Shows Superiority Compared ...

    Benzinga
  27. Can Pfizer Make Up Its Loss?

    GuruFocus
  28. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  29. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  30. Will Pfizer's Q1 2014 Earnings Beat the Street on May 5, 2014?

    GuruFocus
  31. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  32. Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss

    IBD
  33. Novo Nordisk Q1 Revenue Misses; Guidance Lowered

    IBD
  34. Vanguard Health Care Fund's Top Quarterly Holdings

    GuruFocus
  35. Actavis Earns Over-The-Top Q1

    IBD
  36. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD
  37. Actavis Q1 Earnings Beat On Generic Cymbalta Surprise

    IBD
  38. China Rule Change Further Opens Yuan To World Markets

    IBD
  39. These Three Pharmaceutical Companies Shake The Market With Their ...

    GuruFocus
  40. Drugmakers' Q1 was anemic

    IBD
  41. Eli Lilly Jr. Made His Firm A Pharmaceutical Power

    IBD
  42. Earnings Scheduled For April 24, 2014

    Benzinga
  43. Big Pharmas Swap Specialties

    IBD
  44. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  45. Benzinga's M&A Chatter for Tuesday April 22, 2014

    Benzinga
  46. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  47. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  48. Pharma Deal Frenzy: A Bid to Boost Profits, Cut Risk

    FoxBusiness
  49. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  50. Novartis, Glaxo Swap Units; Lilly Buying Animal Biz

    IBD
  51. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  52. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
  53. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  54. Stock Futures Steady Amid Raft of Health M&A

    FoxBusiness
  55. Wall Street Ticks Up as Traders Parse News Deluge

    FoxBusiness
  56. ELI LILLY

    IBD
  57. No Legwork Mondays – Takeda, Eli Lilly, And Actos

    Benzinga
  58. Market Wrap For April 14: Markets Surge on Positive Retail Data, ...

    Benzinga
  59. Lilly, Takeda must pay $9 bil

    IBD
  60. Ethical Drug Stocks Are Struggling

    IBD
  61. UPDATE: BMO Capital Upgrades Eli Lilly

    Benzinga
  62. Takeda, Lilly to 'Vigorously Challenge' Actos Ruling

    FoxBusiness
  63. Benzinga's Top Upgrades

    Benzinga
  64. Takeda Responds to $6B Verdict in Diabetes Drug Case

    Benzinga
  65. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With ...

    Benzinga
  66. Pfizer Breast-Cancer Drug Scores, But Street Cautious

    IBD
  67. Market Wrap For April 3: Markets Winning Streak Fails To Extend ...

    Benzinga
  68. Wide Moat Stocks: Protection In A Correction

    YCharts
  69. UPDATE: Cowen & Company Upgrades Eli Lilly

    Benzinga
  70. Benzinga's Top Upgrades

    Benzinga
  71. Biotech Auxilium Boosts Position In Men's Health Care

    IBD
  72. Lilly Expands Generic Deal With Prasco

    FoxBusiness
  73. UPDATE: Bank of America Reiterates on Eli Lilly and Co. Following ...

    Benzinga
  74. Merck Snags Baxter Executive As CFO

    FoxBusiness
  75. Box, Online Storage Service Provider, Files For IPO

    IBD
  76. Which Pharmas Can Keep Up Dividend-Buybacks?

    YCharts
  77. Forest Laboratories' Recovery

    GuruFocus
  78. Pfizer Breast-Cancer Drug To Show If It's For Real

    IBD
  79. Pharma Patent Cliff: Why Worst Seems Over

    YCharts
  80. Elanco Announces Agreement to Acquire Lohmann Animal Health; ...

    Benzinga
  81. Actavis Q4 Beats Street; Guidance Affirmed For Now

    IBD
  82. Eli Lilly up on lung cancer trial

    IBD
  83. Market Wrap For February 19: Stocks Close Lower, Nasdaq Ends ...

    Benzinga
  84. Lilly Drug Ramucirumab Boosts Lung Cancer Survival

    IBD
  85. Stocks Stage Quiet, Mixed Open; Eli Lilly Up, U.S. Steel Tanks

    IBD
  86. Actavis, Valeant, Jazz: New Roles For Specialty Pharma

    IBD
  87. #PreMarket Primer: Friday, January 31: Emerging Market Turmoil ...

    Benzinga
  88. Eli Lilly

    IBD
  89. Market Wrap For January 30: Markets Focus on Good News

    Benzinga
  90. Lilly's Cymbalta to Trigger 'Severe' Sales Slide

    FoxBusiness
  91. UPDATE: Eli Lilly Posts Drop In Q4 Profit

    Benzinga
  92. #PreMarket Primer: Thursday, January 30: Fed Cut Stimulus By ...

    Benzinga
  93. Tug Of War In Ariad Pharmaceuticals

    Benzinga
  94. Benzinga's M&A Chatter for Monday January 27, 2014

    Benzinga
  95. Income + Value Investing: YCharts Sector Report

    YCharts
  96. Benzinga Weekly Preview: Tech Sector To Steal The Spotlight

    Benzinga
  97. Ariad Shares Continue to Surge Amidst Buyout Rumors

    Benzinga
  98. Is The Market On Drugs?

    Benzinga
  99. AstraZeneca: Time to Make a Bet? Steven Cohen Seems to Think ...

    GuruFocus
  100. Wide Moat Stocks Against Two Value Systems

    YCharts
Trading Center